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Abstract
Background: Deletions of chromosome 22q11 are present in over 90% of cases of DiGeorge or Velo-Cardio-Facial
syndrome (DGS/VCFS). 15q11-q13 duplication is another recognized syndrome due to rearrangements of several
genes, belonging to the category of imprinted genes. The phenotype of this syndrome varies but has been clearly
associated with developmental delay and autistic spectrum disorders. Co-existence of the two syndromes has not
been reported so far.
Results: Here we report a 6-year-old boy presenting growth retardation, dysmorphic features and who exhibited
learning difficulties. Fluorescence in situ hybridization (FISH) analysis of the proband revealed a deletion of
DiGeorge Syndrome critical region (TUPLE). Array-CGH analysis revealed an interstitial duplication of 12 Mb in size
in the area 15q11.2-q13.3, combined with a 3.2 Mb deletion at region 22q11.1-q11.21. FISH analysis in the mother
showed a cryptic balanced translocation between chromosome 15 and chromosome 22 (not evident by classic
karyotyping).
Discusion: The clinical manifestations could be related to both syndromes and the importance of array-CGH
analysis in cases of unexplained developmental delay is emphasized. The present case further demonstrates how
molecular cytogenetic techniques applied in the parents were necessary for the genetic counseling of the family.
Background
DiGeorge syndrome and Velo-Cardio-Facial syndrome
(DGS/VCFS) are the result of deletions of chromosome
22q11.2 in over 90% of cases [1]. The cardinal features
and symptoms are cellular immunodeficiency due to
thymus hypo or aplasia, hypocalcemia because of
absence of the parathyroid, congenital heart defect with
high mortality and morbidity, and typical faces [2]. The
prevalence of the syndrome is estimated (probably
underestimated) to approximately 1:4,500 and represents
one of the commonest genetic diseases [3].
The 4 Mb 15q11-q13 region, containing three bialleli-
cally expressed genes, which encode receptor subunits
for the inhibitory neurotransmitter gamma-aminobutyric
acid (GABRB3, GABRA5 and GABRG3), is prone to
structural rearrangements [4,5]. Duplications of this
region occurring on the maternal chromosome, have
been associated with a complex neurobehavioral pheno-
type that often includes language delay, seizures and
autism (OMIM# 608636) [6-11,4].
Clayton-Smith et al (1993) had initially reported a
patient with a 15q11-q13 duplication including the
Angelman syndrome critical region (ASCR), who had
ataxia and moderate developmental delay, particularly of
language, but neither epilepsy nor behavioural problems
[12]. Subsequently, Bundey et al (1994) reported a boy
with mental retardation, infantile autism, ataxia, and sei-
zures, who had a more extensive interstitial duplication
of 15q11-q13, including the critical regions for Prader
Willi syndrome (PWS) and AS on the maternally
derived chromosome [13]. Since then, various similar
cases have been published and according to the
* Correspondence: emanolakosgr@yahoo.gr
1Bioiatriki S.A., Laboratory of Genetics, Athens, Greece
Full list of author information is available at the end of the article
Manolakos et al. Molecular Cytogenetics 2011, 4:6
http://www.molecularcytogenetics.org/content/4/1/6
© 2011 Manolakos et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.literature duplications of the 15q11-q13 region consti-
tute the most frequently reported chromosomal aberra-
tion in individuals with Autism Spectrum Disorders
(ASDs) [11]. Recently, our team reported the largest
contiguous de novo interstitial duplication (15q11.2-
q14) of the PWS/AS region (17.7 Mb) of maternal origin
[14]. The study though by Szafranski et al (2010) of a
cohort of patients with small duplications (<1.6 Mb) at
15q13.2-q13.3 involving the CHRNA7 gene suggested
association with developmental delay, mental retarda-
tion, muscular hypotonia and various neuropsychiatric
disorders but did not prove clinical significance [15].
The use of array-CGH has increased the resolution
available to studies of chromosomal abnormalities, from
≥ 5 Mb, achieved by metaphase Fluorescence in situ
hybridization (FISH), to >100 kb, or the size of a Bacter-
ial Artefact Clone (BAC clone), to <16.4 kb average spa-
tial resolution with oligonucleotide arrays. Especially the
higher resolution arrays are able to define the break-
point of rearrangements and to accurately detect copy
number.
Here we present the clinical and molecular findings in
a 6-year-old boy with a duplication of about 12.9 Mb
that involves the region 15q11.2-q13.3 along with a
deletion of approximately 3.2 Mb on the long arm of
chromosome 22, at the region 22q11.1-q11.21. The sizes
and breakpoints of the deletion and duplication were
determined through oligo array-CGH analysis. To our
k n o w l e d g et h i si st h ef i r s tc a s eo fc o n c u r r e n c eo f
DiGeorge syndrome with a maternally inherited
15q12.2-q13.3 duplication. The aim of this study is to
correlate the molecular findings with the proband’s clin-
ical phenotype and to demonstrate that molecular cyto-
genetic techniques used in the parents were necessary
for the genetic counseling of the family.
Case presentation
The proband, a 6-year-old boy, is the first child of
non-consanguineous, healthy 30 year-old parents. The
family history was unremarkable. Pregnancy was
uneventful, there was no prenatal exposure to terato-
gens but the prenatal ultrasound examination showed
exadactyly (right hand). Amniocentesis revealed a nor-
mal karyotype 46,XY. The proband was born at
35 weeks of gestation by normal delivery, with birth
weight of 2600 g, length 49 cm and head circumfer-
ence 31 cm, all within normal range for the age of
gestation. Apgar scores were 9/1” and 10/5” and he
had an uncomplicated perinatal period. At birth he
presented radial exadactyly and syndactyly of 3
rd and
4
th fingers (right) as well as a radial ulnar (left) rudi-
mentary supernumerary finger and other malforma-
tions. Ultrasound of brain/abdomen and cardiovascular
examination were normal.
Radiological re-examination of the right hand at the
first year of life showed syndactyly of the 3
rd and 4
th
fingers and a supernumerary dysplastic finger which
was surgically removed. Two years later surgical axonal
repair of the syndactyly was performed and since
then the patient has been regularly followed up by
orthopaedists.
His initial motor development was slightly retarded;
head control was achieved at the age of 5 months, unsup-
ported sitting at 16 months and walking at 18 months.
His language acquisition was also delayed. Early develop-
mental intervention with physiotherapy and sessions for
speech improvement showed gradual but not remarkable
progress. Audiologic evaluation revealed congenital sen-
sorineural hearing loss bilaterally (80-90 dB) which was
not attributed to the 35delG mutation of the connexin
26 gene (GJB2) after molecular analysis by PCR [16].
Fragile-X syndrome was also excluded, while MRI of the
brain was within normal limits.
During three hospitalizations at the age of 4 and
5 years due to recurrent right lung pneumonia, extended
immunologic studies excluded immunodeficiency. Rou-
tine blood and urine biochemical investigations as well
as thorough metabolic and endocrinological evaluation
showed no abnormality while ophthalmologic evaluation
revealed hypermetropy. The examination of internal
organs by ultrasonography was also negative for any
pathology.
The boy was referred for genetic evaluation at the
age of 6 years. He showed growth retardation [height at
105 cm (<3
rd centile), weight 17 kg (3
rd centile), head
circumference 49.5 cm (3
rd centile)], made 2-5 word
phrases and exhibited learning difficulties. Dysmorphic
features included facial weakness, blepharoptosis (not
myopathetic type), downslanting palpebral fissures, epi-
canthus, full cheeks, thick/small/low-set/dysplastic ears,
high-arched palate, chin dimpling, bulbous nasal tip,
and microstomia.
Results
Chromosome analysis of the proband was performed
using GTG-banding techniques on stimulated blood
lymphocytes. Cytogenetics revealed a normal karyotype
46,XY (Figure 1).
Due to the clinical findings fluorescence in situ hybri-
dization (FISH) using a probe specific for DiGeorge Syn-
drome critical region (TUPLE) was performed. A single
red signal could be seen on the normal chromosome 22
(Figure 2), while the red signal was absent on the homo-
logous chromosome 22. Two green signals were seen on
the subtelomere of both homologues (control probe).
Due to atypical clinical findings molecular karyotyping
was performed through array-CGH analysis on the pro-
band’s DNA by using an Agilent 60 K array platform.
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Page 2 of 8This analysis showed a 22q11.1-q11.21 deletion of about
3.2 Mb, with distal breakpoint falling between
18,691,704 bp (last deleted oligomer) and 19,084,422 bp
(first normal oligomer). The first oligomer on the plat-
form for proximal 22q maps at 15,476,855 bp and
resulted to be deleted. The analysis also detected a
duplication of about 12.9 Mb that involves the 15q11.2-
q13.3 region, with distal breakpoint falling between
31,288,255 bp (last duplicated oligomer) and 31,339,610
bp (first normal oligomer). The first oligomer on the
platform for proximal 15q maps at 18,362,555 bp and
was duplicated (Figure 3).
Parental karyotypes were normal. Parental FISH analy-
sis was requested and the mother was found to carry a
cryptic balanced translocation between chromosome 15
and chromosome 22 with a 46,XX,t(15;22)(q11.2;q11.2)
karyotype (Figure 4) using the following two probes
[TUPLE and TBX1 DiGeorge Region probes (Cytocell)].
The karyotype of the proband was defined as follows:
46,XY,ish der(22)t(15;22)(q11.2;q11.2)(TUPLE-,TBX-)
mat.
According to fragment analysis three alleles were
observed in the proband using microsatellite markers
Figure 1 Patient’s karyotype (GTG-banding).
Figure 2 FISH analysis of the proband using a probe (labeled
red) specific for DiGeorge Syndrome critical region (TUPLE).A
single red signal (white arrow) can be seen on the normal
chromosome 22, while the red signal is absent on the chromosome
22 with the deletion. Two green signals are seen on the
subtelomeres of both homologues (control probe).
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Page 3 of 8D15S122, D15S113 and D15S97, all within the PWS/AS
critical region. The markers were not informative of the
parental origin of the partial trisomy 15. Biparental
inheritance of chromosome 15 was observed with mar-
ker 85CA.
Discussion
The long arm of chromosome 15 and essentially the
15q11.2-q14 PWS/AS region is highly susceptible to
clinically important genomic rearrangements, including
interstitial deletions, duplications, and triplications
[17,18]. Transcriptional regulation of the 15q11-q14
region is highly complex, involving multiple allele-speci-
fic epigenetic marks, including DNA methylation, his-
tone modification patterns and DNAse hypersensitive
sites [19]. The area also contains a cluster of snoRNA
and noncoding RNAs, which are under specific imprint-
ing regulation [20]. Repeat sequences, such as low copy
repeats (LCR) are thought to mediate misalignment of
the region during meiosis, leading to unequal recombi-
nation events [14].
Duplications reported so far usually share two proxi-
mal Breakage Points (BPs) (BP1 and BP2) and usually
one distal BP3 and include PWACR.M o r ed i s t a lB P s
(BP4 and BP5) are involved in large inv-dup(15)s and
intrachromosomal triplications [17,21]. The frequency of
15q11-q13 interstitial duplications is estimated at 1:600
individuals referred with developmental delay [22].
Interstitial duplications of proximal 15q that do not
include the PWS/AS critical region have no clinical
effect, are usually familial, and may be considered nor-
mal variants [23]. Patients with interstitial duplications
of the PWS/AS locus have an abnormal phenotype that
includes developmental delay, particularly affecting
speech and language; varying degrees of mental retarda-
tion; autism or autistic features; motor coordination
Figure 3 Molecular characterization of the proband showed a 3.2 Mb 22q11.1q11.21 deletion and a 12.9 Mb 15q11.2-q13.3
duplication. The small duplicated region visible under the 3.2 Mb deletion on chromosome 22q is a known benign CNV related to the
reference DNA used in the experiment (NA10851).
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The phenotype is highly variable, even among members
of the same family carrying identical rearrangements
[24] and can in some cases manifest as developmental
language disorder and dyspraxia, without autism [25].
Increased dosage of the PWS/AS critical gene region
between BP2 and BP3 positively correlates with pheno-
typic severity in patients with 15q11-q13 duplications,
however clinical heterogeneity in patients is not
explained by variation in breakpoints only, suggesting
that additional factors contribute to clinical complexity.
At least 33 cases of interstitial duplications of the
15q11-q13 region have been reported in association
with ASDs, according to the Autism Chromosome Rear-
rangement Database (http://projects.tcag.ca/autism/).
Overexpression of maternally imprinted genes through
duplication of chromosome 15q11-q14 also displays par-
ent-of-origin effects, with maternal duplications being
associated with a complex neurobehavioral phenotype
that often includes autism, cognitive deficits and sei-
zures [10,11,4]. Twenty-five cases with maternal origin
of the intrachromosomal duplication showed a range of
phenotypic features from severe mental retardation,
developmental delay, seizures, nonspecific hypotonia,
and mild facial anomalies to only developmental delay
and autism [16,24,26,27].
O n ec a s eo fa u t i s t i cd i s o r d e ra s s o c i a t e dw i t hap a t e r -
nally derived unbalanced translocation leading to dupli-
cation of chromosome 15pter-q13.2 has been reported,
suggesting that biallelically expressed genes on proximal
15q contribute to the autism phenotype [28].
Regarding the developmental outcome of our proband,
he lacked seizures and autistic behavior which have been
associated with 15q11-q13 duplication. He had marked
psychomotor delay, expressed primarily as poor speech,
probably attributed to the 15q11-q13 duplication since
22q11 deletion mostly causes mild retardation [1,14].
Congenital heart defects, mainly of the cardiac outflow
tract and aortic arch, commonly severe, are present in 75%
of patients with DiGeoge syndrome and are possibly asso-
ciated with TBX1 haploinsufficiency [29]. In our proband
though, the congenital heart defect was restricted to tran-
sient patent foramen ovale which is a simple and non life-
threatening anomaly. Within the spectrum of DGS/VCFS,
small ears and deafness are listed, but usually the latter is
conductive and when sensorineural, as in our patient, is
bilateral. Our proband was lacking several of the most
common features referred within the clinical spectrum of
del22q11.2-q11.21, as immunodeficiency, various endocri-
nological manifestations and hypocalcemia [3]. The poly-
dactyly (either pre- or postaxial) has also been described,
but not syndactyly that the patient also demonstrated. The
frequency of inherited 22q11.2 deletions reported by Ryan
et al 1997 [30], is much higher than in previous studies
(28% versus 10%, respectively) and it has been suggested
that both parents should be investigated in any case of
DGS/VCFS [31,32]. Mosaic cases of 22q11.2 microdeletion
syndrome seem very rare [33].
Figure 4 FISH analysis of the mother using a probe (labeled red) specific for DiGeorge Syndrome critical region (TUPLE) and
schematic representation of the corresponding breakpoints on chromosomes 15 and 22. A. A red signal together with a green signal
(subtelomere specific) can be seen on the normal chromosome 22. However in the homologous chromosome 22 only one green signal can be
seen, while the red signal is translocated on to a chromosome of the D group depicting that the mother bears a cryptic translocation. B. An
ideogram scheme of the breakpoints (red arrows) on chromosomes 15 and 22 that resulted in a balanced translocation in the mother.
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healthy parents was reported [34] in a case where FISH
showed a t(1;17)(q44;p13.2) translocation in the father,
which subsequentlye n a b l e dt h ec h a r a c t e r i z a t i o no ft h e
der(1) chromosomal abnormality in the index patient. It
is important that cryptic translocations are kept in
mind, and that parental karyotypes are analyzed in cases
of mentally retarded children with normal karyotype.
Our report adds another case of maternal origin of
15q11-q13 duplication in the current literature and
shows again the syndrome variability which becomes
more obscure when accompanied by another chromoso-
mal abnormality, as 22q11 deletion. Furthermore, it
represents, as far as we know, the first case of concur-
rence of 22q11.1-q11.21 deletion (mat) with 15q11.2-
q13.3 duplication. It illustrates the value of thorough
clinical evaluation and multiple genetic tests in patients
with unexplained developmental delay and major conge-
nital anomalies as well as in their parents with the
scope of excluding possible balanced translocations pre-
disposing to genetic risk. We suggest that reporting of
similar well-characterized clinical cases with clearly deli-
neated breakpoints of the duplicated region will clarify
the contribution of specific genes to the phenotype and
will offer accurate genotype versus phenotype correla-
tion that should allow a more precise prognosis.
Materials and methods
Chromosome analysis and FISH
Chromosome analysis was carried out on PHA-stimu-
lated lymphocytes with standard GTG-banding techni-
que. FISH studies were performed by use of the
standard method described by Pinkel et al (1988) [35].
Hybridization signals were detected by two digoxigenin
(DIG) - probes according to the manufacturer’s instruc-
tions. The probes used were DiGeorge and 22q13.3
Deletion Syndrome Probe Combinations (Cytocell). Two
out of three commercially available probes from Cytocell
were used:
1) VCFS TUPLE 1 Region deletion probe, labeled in
red which measures approximately 120 kb and covers
the entire TUPLE1 gene and flanking DNA,
2) TBX1 Region deletion probe labeled in red, which
is approximately 213 kb, and contains the D22S1627
marker. Both are DIG-probes directly labeled with a red
fluorochrome (Texas Red spectrum) and accompanied
by the 22 telomere control probe directly labeled with a
green fluorophore (FITC spectrum).
A total of 40 metaphases from each probe of the pro-
band and a total of 20 metaphases from each probe of
the carrier mother were examined after the hybridiza-
tion and the number and relative position of signals
were recorded. Signal distribution and intensity from
the normal chromosome 22 homologue acted as an
internal control for the efficiency and stringency of the
hybridization experiment. Analysis was performed by
use of a conventional Zeiss epifluorescent Axioskop
2plus microscope, and images were captured, enhanced
a n da n a l y z e db yu s eo fC y t o v i s i o n( A p p l i e dI m a g i n g )
software. Both the conventional cytogenetics and FISH
results were described according to the 2009 Interna-
tional System for Human Cytogenetics Nomenclature
(ISCN) [36].
Molecular karyotyping
Molecular karyotyping was carried out on DNA extracted
from whole blood of the patient and both his parents
according to standard procedures. All the experiments
were conducted through oligo array-CGH platforms (Sur-
ePrint G3 Human CGH Microarray, 8 × 60 K, Agilent
Technologies, Santa Clara, CA, USA). Briefly 500 ng of the
proband and of a sex-matched reference DNAs
(NA10851, Coriell Cell Repositories) were processed
according to the manufacturer’s protocol. Fluorescence
was scanned in a dual-laser scanner (DNA Microarray
Scanner with Sure Scan High-Resolution Technology,
Model G2565CA, Agilent Technologies, Santa Clara, CA,
USA) and the images were extracted and analyzed through
Agilent Feature Extraction Software (v10.5.1.1). Graphical
overview was obtained using the DNA Analytics software
(v4.0.73). Changes in test DNA copy number at a specific
locus were observed as the deviation of the log2 ratio value
of 0 of at least three consecutive probes. The quality of
each experiment was assessed by using a parameter pro-
vided by Agilent software (QC metric). Copy number
changes identified in the samples were visualized by using
the UCSC Genome Browser website (http://genome.ucsc.
edu) and also compared to the Database of Genomic Var-
iants (http://projects.tcag.ca/variation) to exclude copy
number changes considered as benign variants. The posi-
tions of oligomers refer to the Human Genome March
2006 (versions NCBI 36, hg18) assembly. The DECIPHER
(https://decipher.sanger.ac.uk/) and ECARUCA (http://
agserver01.azn.nl:8080/ecaruca/ecaruca.jsp) databases
were expedient as resources to aid genotype-phenotype
correlation.
Fragment analysis
Chromosome 15 microsatellite markers 85CA, D15S122,
GABRB3, D15S113, CYP19, D15S97, and FES were gen-
otyped. The DNA fragments were amplified by polymer-
ase chain reaction (PCR) and the products were further
diluted in Hi-Di™ formamide and GeneScan™ 500
LIZ
® which were used as an internal lane size standard
in order to enable automated data analysis and precise
DNA fragment size comparisons between electrophor-
esis runs. The final products were separated by capillary
electrophoresis on an ABI 310 genetic analyzer (Applied
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Page 6 of 8Biosystems, Foster City, CA, USA) according to the
manufacturer’s protocol and the results were evaluated
using the GeneMapper v4.0 software (Applied Biosys-
tems, Foster City, CA, USA).
Consent
Written informed consent was obtained from the par-
ents of the patient for publication of this case report
and accompanying images. A copy of the written con-
sent is available for review by the Editor-in-Chief of this
journal.
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